Arteriovenous anastomosis: Is this the way to control hypertension?

Hypertension

Volumn 64, Issue 1, 2014, Pages 6-12

  Burchell, Amy E ^a   Lobo, Melvin D ^b,c   Sulke, Neil ^d   Sobotka, Paul A ^e   Paton, Julian F R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Centre for Clinical Pharmacology   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

^d EASTBOURNE DISTRICT GENERAL HOSPITAL   (United Kingdom)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ANASTOMOTIC DEVICE; ANTIHYPERTENSIVE ACTIVITY; ARTERIOVENOUS FISTULA; ARTERY BLOOD FLOW; ARTERY COMPLIANCE; ARTERY STEAL SYNDROME; BLOOD PRESSURE REGULATION; BLOOD VOLUME; CARDIOPULMONARY FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDEMA; HEART AFTERLOAD; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEART RATE; HEART RIGHT ATRIUM PRESSURE; HEART STROKE VOLUME; HEART VOLUME; HEART WORK; HEMODYNAMICS; HIGH OUTPUT HEART FAILURE; HUMAN; HYPERTENSION; ILIAC ARTERY; ILIAC VEIN; KIDNEY BLOOD FLOW; LUNG BLOOD FLOW; OUTCOME ASSESSMENT; OXYGENATION; PERIPHERAL EDEMA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESISTANT HYPERTENSION; REVIEW; RISK FACTOR; STARLING LAW; SYSTEMIC VASCULAR RESISTANCE; THROMBOSIS; VASCULAR DISEASE; VASCULAR RESISTANCE; VENOUS CIRCULATION; VENOUS RETURN;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; HYPERTENSION;

EID: 84902533311     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.02925     Document Type: Review

References (42)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365: 217-223.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360: 1903-1913.
3. Lloyd A, Schmieder C, Marchant N. Financial and health costs of uncontrolled blood pressure in the United Kingdom. Pharmacoeconomics. 2003;21(Suppl 1): 33-41.
4. Carey RM. Resistant hypertension. Hypertension. 2013;61: 746-750.
5. Plump A. Accelerating the pulse of cardiovascular R&D. Nat Rev Drug Discov. 2010;9: 823-824.
6. Cooper CB, Celli B. Venous admixture in COPD: pathophysiology and therapeutic approaches. COPD. 2008;5: 376-381.
7. Holman E. Abnormal arteriovenous communications. Great variability of effects with particular reference to delayed development of cardiac failure. Circulation. 1965;32: 1001-1009.
8. Faul JL, Galindo J, Posadas-Valay R, Elizondo-Riojas G, Martinez A, Cooper CB. An arteriovenous fistula increases exercise capacity in patients with COPD. Chest. 2010;138: 52-58.
9. Bertog SC, Kolmer C, Kleschnew S, Franke J, Wunderlich N, Kardos P, Sievert H. Percutaneous femoral arteriovenous shunt creation for advanced chronic obstructive pulmonary disease: a single-center safety and efficacy study. Circ Cardiovasc Interv. 2012;5: 118-126.
10. Korsheed S, Eldehni MT, John SG, Fluck RJ, McIntyre CW. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function. Nephrol Dial Transplant. 2011;26: 3296-3302.
11. Faul JL, Smyth RJ, Cormican LJ, Burke CM. Percutaneous Femoral Arteriovenous Shunt Creation for Advanced Chronic Obstructive Pulmonary Disease: A Single-Center Safety and Efficacy Study. Circ Cardiovasc Interv. 2012;5:e45-e45.
12. Palatini P, Casiglia E, Ga̧sowski J, Głuszek J, Jankowski P, Narkiewicz K, Saladini F, Stolarz-Skrzypek K, Tikhonoff V, Van Bortel L, Wojciechowska W, Kawecka-Jaszcz K. Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension. Vasc Health Risk Manag. 2011;7: 725-739.
13. Paton JF, Dickinson CJ, Mitchell G. Harvey Cushing and the regulation of blood pressure in giraffe, rat and man: introducing 'Cushing's mechanism'. Exp Physiol. 2009;94: 11-17.
14. Ori Y, Korzets A, Katz M, Perek Y, Zahavi I, Gafter U. Haemodialysis arteriovenous access-a prospective haemodynamic evaluation. Nephrol Dial Transplant. 1996;11: 94-97.
15. Siński M, Lewandowski J, Przybylski J, Bidiuk J, Abramczyk P, Ciarka A, Gaciong Z. Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res. 2012;35: 487-491.
16. Faul JL, Sievert H. Percutaneous Creation of Arteriorvenous Shunts. Vascular Disease Management. 2008;5: 111-115.
17. Guyton AC, Sagawa K. Compensations of cardiac output and other circulatory functions in areflex dogs with large A-V fistulas. Am J Physiol. 1961;200: 1157-1163.
18. MacRae JM, Pandeya S, Humen DP, Krivitski N, Lindsay RM. Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis. 2004;43:e17-e22.
19. Iwashima Y, Horio T, Takami Y, Inenaga T, Nishikimi T, Takishita S, Kawano Y. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis. 2002;40: 974-982.
20. Hainsworth R. Reflexes from the heart. Physiol Rev. 1991;71: 617-658.
21. Hainsworth R. Cardiovascular control from cardiac and pulmonary vascular receptors. Exp Physiol. 2014;99: 312-319.
22. Moore JP, Hainsworth R, Drinkhill MJ. Reflexes from pulmonary arterial baroreceptors in dogs: interaction with carotid sinus baroreceptors. J Physiol. 2011;589(Pt 16): 4041-4052.
23. Winternitz SR, Oparil S. Importance of the renal nerves in the pathogenesis of experimental hypertension. Hypertension. 1982;4(5 Pt 2):III108-III114.
24. Bourquelot P, Rawa M, Van Laere O, Franco G. Long-term results of femoral vein transposition for autogenous arteriovenous hemodialysis access. J Vasc Surg. 2012;56: 440-445.
25. Sherev DA, Shaw RE, Brent BN. Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention. Catheter Cardiovasc Interv. 2005;65: 196-202.
26. MacRae JM. Vascular access and cardiac disease: is there a relationship? Curr Opin Nephrol Hypertens. 2006;15: 577-582.
27. Vajdič Trampuž B, Ponikvar R, Kandus A, Buturović-Ponikvar J. Hemodialysis arteriovenous fistula-related complications and surgery in kidney graft recipients. Ther Apher Dial. 2013;17: 444-447.
28. Malík J, Tuka V, Mokrejsová M, Holaj R, Tesar V. Mechanisms of chronic heart failure development in end-stage renal disease patients on chronic hemodialysis. Physiol Res. 2009;58: 613-621.
29. De Lima JJ, Vieira ML, Molnar LJ, Medeiros CJ, Ianhez LE, Krieger EM. Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft. Cardiology. 1999;92: 236-239.
30. Gorgulu N, Caliskan Y, Yelken B, Akturk F, Turkmen A. Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients. Int J Artif Organs. 2011;34: 1024-1030.
31. Unger P, Xhaët O, Wissing KM, Najem B, Dehon P, van de Borne P. Arteriovenous fistula closure after renal transplantation: a prospective study with 24-hour ambulatory blood pressure monitoring. Transplantation. 2008;85: 482-485.
32. Movilli E, Viola BF, Brunori G, Gaggia P, Camerini C, Zubani R, Berlinghieri N, Cancarini G. Long-term effects of arteriovenous fistula closure on echocardiographic functional and structural findings in hemodialysis patients: a prospective study. Am J Kidney Dis. 2010;55: 682-689.
33. Unger P, Velez-Roa S, Wissing KM, Hoang AD, van de Borne P. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant. 2004;4: 2038-2044.
34. van Duijnhoven EC, Cheriex EC, Tordoir JH, Kooman JP, van Hooff JP. Effect of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant. 2001;16: 368-372.
35. Liu Z, Hilbelink DR, Crockett WB, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 1. Developing and established hypertrophy. Circ Res. 1991;69: 52-58.
36. Liu Z, Hilbelink DR, Gerdes AM. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas. 2. Long-term effects. Circ Res. 1991;69: 59-65.
37. Malík J, Tuka V, Krupickova Z, Chytilova E, Holaj R, Slavikova M. Creation of dialysis vascular access with normal flow increases brain natriuretic peptide levels. Int Urol Nephrol. 2009;41: 997-1002.
38. Unal A, Tasdemir K, Oymak S, Duran M, Kocyigit I, Oguz F, Tokgoz B, Sipahioglu MH, Utas C, Oymak O. The long-term effects of arteriovenous fistula creation on the development of pulmonary hypertension in hemodialysis patients. Hemodial Int. 2010;14: 398-402.
39. Acarturk G, Albayrak R, Melek M, Yuksel S, Uslan I, Atli H, Colbay M, Unlu M, Fidan F, Asci Z, Cander S, Karaman O, Acar M. The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients. Int Urol Nephrol. 2008;40: 509-513.
40. Miles AM. Vascular steal syndrome and ischaemic monomelic neuropathy: two variants of upper limb ischaemia after haemodialysis vascular access surgery. Nephrol Dial Transplant. 1999;14: 297-300.
41. Taylor SM, Eaves GL, Weatherford DA, McAlhany JC Jr, Russell HE, Langan EM 3rd. Results and complications of arteriovenous access dialysis grafts in the lower extremity: a five year review. Am Surg. 1996;62: 188-191.
42. Dikow R, Schwenger V, Zeier M, Ritz E. Do AV fistulas contribute to cardiac mortality in hemodialysis patients? Semin Dial. 2002;15: 14-17.